Alvine Pharmaceuticals Inc;The Board of Trustees of the Leland Stanford Junior UNIV
发明人:
Shan, Lu,Bethune, Michael,Khosla, Chaitan,Gass, Jonathan
申请号：
NO20065195
公开号：
NO340598B1
申请日:
2006.11.13
申请国别(地区):
NO
年份:
2017
代理人:
摘要：
Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten.
